30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Del Carmen Jeffrey

Insider profile

Performance

Overall performance
2.9

Performance over holding periods
2.9
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 17% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Del Carmen Jeffrey's trades of Catalyst Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-11-28 2025-11-26 S Sale
97,089 +42.4%
261.70
US$3,466,388
97,089 +42.4% 261.70 US$3,466,388
2025-11-26 2025-11-26 PrS Proposed sale
74,604
236.94
US$2,312,203
74,604 236.94 US$2,312,203
2025-03-05 2025-03-03 S Sale
94,523 -39.9%
354.62
US$2,843,736
94,523 -39.9% 354.62 US$2,843,736
2025-03-03 2025-03-03 PrS Proposed sale
30,423
22.89
US$696,382
30,423 22.89 US$696,382
2024-08-13 2024-08-09 S Sale
30,000 -70.8%
18.42
US$552,600
30,000 -70.8% 18.42 US$552,600
2024-08-13 2024-08-09 S Sale
6,058 -32.9%
18.44
US$111,710
6,058 -32.9% 18.44 US$111,710
2024-08-09 2024-08-09 PrS Proposed sale
36,058
18.42
US$664,348
36,058 18.42 US$664,348
2024-06-11 2024-06-07 S Sale
7,541 -29.0%
16.07
US$121,184
7,541 -29.0% 16.07 US$121,184
2024-06-07 2024-06-07 PrS Proposed sale
7,541
16.07
US$121,184
7,541 16.07 US$121,184
2023-03-30 2023-03-29 S Sale
19,017 -71.6%
16.69
US$317,394
19,017 -71.6% 16.69 US$317,394
2023-03-30 2023-03-29 S Sale
20,983 -73.6%
16.70
US$350,416
20,983 -73.6% 16.70 US$350,416
2022-11-15 2022-11-11 S Sale
19,017 -100.0%
15.46
US$294,022
19,017 -100.0% 15.46 US$294,022
2022-11-15 2022-11-11 S Sale
120,000 -100.0%
16.23
US$1,947,360
120,000 -100.0% 16.23 US$1,947,360